Aurora Cannabis Inc. completes US$165 million cross-border offering

On Nov. 16, Aurora Cannabis Inc. (TSX:ACB) (NYSE: ACB) completed a US$165 million cross-border offering of units pursuant to a supplement to its base shelf prospectus. Each unit consists of one common share and one half of one common share purchase warrant. The units were sold through a syndicate of underwriters led by BMO Capital Markets and AltaCorp and including CIBC Capital Markets.

Aurora Cannabis plans to use the net proceeds of the offering to fund growth opportunities, working capital and other general corporate purposes. Aurora Cannabis is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora Cannabis is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ‘71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

McMillan LLP acted as Canadian legal counsel to Aurora Cannabis with a team led by
Cory Kent (capital markets),
and which included
Marina Tran,
Jason Haley (capital markets),
Peter Botz (tax). 

Jenner & Block LLP acted as U.S. legal counsel to Aurora Cannabis with a team led by
Martin Glass (securities),
and which included
Kirsten Iglesias (securities),
Geoffrey Davis (tax). 

Blake, Cassels & Graydon LLP acted as Canadian legal counsel to the underwriters with a team led by
Tim Andison,
and which included,
Tim Phillips,
Ted Gotlieb,
Elizabeth Litwack-Landsberg,
Galen Miller.

Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as U.S. counsel to the underwriters with a team led by
Adam Givertz,
and which included
Christian Kurtz,
Thea Winterton-Perks,
Cristina Voicu.